Navigation Links
Surprise: Viruses Can Cause Disease during Latent Phase; New Evidence Supports Microcompetition Theory
Date:11/15/2013

Rochester, NY (PRWEB) November 15, 2013

The CDC says that over 776,000 people are newly infected with HSV-2 every year in the United States (1), according to a page last updated on February 11, 2013. The number of cases of HSV-1 is even higher. Doctors and scientists know that herpes viruses 1 and 2 establish a latent infection in the host that lasts for the life. However, these health professionals believe that latent herpes viruses cause disease only when they reactivate. That is, when they cause fever blisters, cold sores, etc.

This is a misconception.

Health professionals may then ask “How is this a misconception?” Or, more specifically, “How can a virus cause disease during latency?”

The CBCD reviews a study that summarizes the most recent discoveries regarding latent herpes viruses.

It should be noted that latency is an essential mechanism of survival for the virus. Without latency, the virus would disappear. Therefore, latency is a widespread mechanism used by many viruses. Authors of this study wrote that “The mission of HSV-1 and HSV-2 is to replicate and spread. To spread, the virus replicates vigorously at the portal of entry and is transmitted by physical contact between infected and uninfected individuals. In effect, the portal of entry into the body is also the portal of transmission. The natural history of HSV in humans strongly suggests that the virus would disappear or at least would be significantly less prevalent if it were not able to establish a latent, silent infection (1).”

However, during the latent phase, the virus is not dormant, it is still active. During the latent phase, it does not produce proteins or replicate in large numbers. It continues to make viral proteins and replicate.

Research shows that latent viruses (including latent herpes viruses) are not dormant. They show viral replication and transcription of viral proteins. For instance, researchers wrote that human ganglia, which were infected with the latent Varicella Zoster Virus, showed multiple VZV transcripts. This is according to a study published on September 4, 2013 in the medical journal Viruses (2).

“RT-PCR and in situ hybridization studies have identified multiple VZV transcripts in latently infected human ganglia. State-of-the-art multiplex PCR technology, capable of detecting all 68 annotated VZV gene transcripts, revealed transcription of at least 12 VZV genes during latency… (2)” In short, the VZV produces its proteins while latent.

How can the production of viral proteins during latency cause disease?

The following is a simplified explanation of the Theory of Microcompetition with Foreign DNA as described by Dr. Hanan Polansky.

Dr. Polansky discovered that foreign DNA fragments, called N-boxes, cause most major diseases. When the foreign N-boxes belong to a virus, microcompetition between the viral DNA and the human DNA can lead to disease even when the virus is latent or the viral DNA is broken into pieces and cannot express proteins.

The Center recommends that health professionals turn to Dr. Polansky’s book, “Microcompetition with Foreign DNA and the Origin of Chronic Disease” for a better understanding of the risks posed by latent viruses.

To learn more about Dr. Hanan Polansky’s research and the Theory of Microcompetition with Foreign DNA, visit: http://www.cbcd.net.

References:

(1)    http://www.ncbi.nlm.nih.gov/pubmed/24024635
(2)    http://www.ncbi.nlm.nih.gov/pubmed/24008377

The CBCD is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments.

The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between foreign DNA and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11333722.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Surprise: Flu Vaccine Prevents Heart Attacks and Strokes; New Study on Flu Vaccine Supports Dr. Hanan Polansky’s Microcompetition Theory
2. New Year Surprise: My Cleaning Products Drops Bed Bug Bully's Price
3. Enteroviruses Cause Type 1 Diabetes; New Studies Support Dr. Hanan Polansky’s Microcompetition Theory
4. Viruses cooperate or conquer to cause maximum destruction
5. When parasites catch viruses
6. IMDx Obtains CE-Marking for an Automated Molecular Test for Detection and Differentiation of Herpes Simplex Viruses 1 and 2
7. GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI)
8. Bacterial protein mops up viruses found in contaminated water supplies
9. NineSigmas Non-Profit Guide to The Grand Challenge Empowers Non-Profit Leaders to Achieve their Mission while Amplifying Awareness of their Cause
10. What Causes Acne? Probiotic Action Shares New Industry Insight on Why the Skin Condition Still Exists
11. What Causes Acne? Adult Acne Treatment, Probiotic Action, Shares Insight on New Culprits Causing Breakouts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... BEIJING , Nov. 30, 2016 ... genomic services and solutions with cutting edge next-generation sequencing ... completed a USD $75 Million [515 Million RMB] B ... International Capital Management ( Shenzhen ) Co., ... ("SDIC Innovation") and Shanghai Sigma Square Investment Center LP ...
(Date:11/30/2016)... -- Part of 5m$ Investment in Integrated Drug ... , ... today announced that it had successfully completed the expansion of ... increased the Screening Collection to over 400,000. The new compounds ... the company. This expansion, complemented by new robotics and compound ...
(Date:11/30/2016)... ... November 30, 2016 , ... SSCI, the established leader in small-molecule cocrystal ... the latest FDA guidance on pharmaceutical cocrystals as drug substance . The ... , The event follows the successful November 15th event that took place in ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... the development of a new orally administered treatment for Alzheimer’s disease (AD), today ... of a Phase 2a clinical trial of T3D-959 in mild to moderate Alzheimer’s ...
Breaking Biology Technology:
(Date:11/14/2016)... Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), a ... challenging operating environments, announced its results for the third ... conference call to discuss these results on November 15, ... Key Recent Accomplishments The ... Vislink Communication Systems. The purchase is expected to close ...
(Date:6/22/2016)... On Monday, the Department of Homeland Security ... solutions for the Biometric Exit Program. The Request for ... (CBP), explains that CBP intends to add biometrics to ... United States , in order to deter visa ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/9/2016)... control systems is proud to announce the introduction of fingerprint attendance control software, allowing ... are actually signing in, and to even control the opening of doors. ... ... ... Photo - http://photos.prnewswire.com/prnh/20160609/377487 ...
Breaking Biology News(10 mins):